Cargando…

Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy

Detalles Bibliográficos
Autores principales:	Foster, Corey C., Lee, Andrew Y., Furtado, Larissa V., Hart, John, Alpert, Lindsay, Xiao, Shu-Yuan, Hyman, Neil H., Sharma, Manish R., Liauw, Stanley L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033459/ https://www.ncbi.nlm.nih.gov/pubmed/29975772 http://dx.doi.org/10.1371/journal.pone.0200400

Ejemplares similares

Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy
por: Foster, Corey C., et al.
Publicado: (2018)

HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues
por: Stanley, Margaret A, et al.
Publicado: (2012)

The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy
por: Hosni, Ali, et al.
Publicado: (2018)

Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation Therapy and Chemotherapy
por: Jiang, Julie M., et al.
Publicado: (2022)

Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy
por: Chauveinc, L, et al.
Publicado: (2003)

Anal HIV DNA is associated with high-risk HPV genotypes in anal cytology specimens obtained for anal neoplasia screening
por: Shiramizu, Bruce, et al.
Publicado: (2012)

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

HPV-Induced Anal and Peri-Anal Neoplasia, a Surgeon’s Experience: 5-Year Case Series
por: Kosmidis, Christoforos, et al.
Publicado: (2023)

Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease
por: Gunder, Laura C., et al.
Publicado: (2023)

Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy
por: Nasioutziki, Maria, et al.
Publicado: (2020)

HPV status and HPV16 viral load in anal cancer and its association with clinical outcome
por: Guerendiain, Daniel, et al.
Publicado: (2022)

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer
por: Mazurek, Agnieszka M., et al.
Publicado: (2023)

Cervical and anal HPV infection and dysplasia in HIV-infected women
por: Stier, EA, et al.
Publicado: (2009)

Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020)

Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy
por: Bolte, Fabian J., et al.
Publicado: (2022)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: lessons from 20 years’ experience
por: Farrell, R., et al.
Publicado: (2022)

A Single Institution Consensus on the Use of Sequential or Concurrent Hormonal Therapy for Breast Cancer Patients Receiving Radiation Therapy
por: Cecchini, Matthew J, et al.
Publicado: (2016)

ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease
por: Ruel, Joannie, et al.
Publicado: (2016)

Seroconversion following anal and genital HPV infection in men: The HIM study
por: Giuliano, Anna R., et al.
Publicado: (2015)

HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM
por: Gosens, Karien C.M., et al.
Publicado: (2021)

Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience
por: Petrillo, Marco, et al.
Publicado: (2020)

Anal High-risk HPV and Liquid-based Cytology of Immunocompetent Brazilian Women with Genital High-risk HPV
por: Melo, Karla Maria Rêgo Leopoldo, et al.
Publicado: (2022)

Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV−ve Oropharynx cancer? A population-based study
por: Hall, Stephen F, et al.
Publicado: (2017)

Persistence of anal squamous intraepithelial lesions and anal HPV infection in HIV-infected patientsdespite immune restoration under cART
por: Piketty, C, et al.
Publicado: (2010)

Anal Cancer and Anal Intraepithelial Neoplasia Risk among Patients Treated for HPV-Related Gynecological Diseases—A Systematic Review
por: Brzeziński, Michał, et al.
Publicado: (2023)

Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy
por: Alexidis, Petros, et al.
Publicado: (2023)

DNA Methylation Profiling across the Spectrum of HPV-Associated Anal Squamous Neoplasia
por: Hernandez, Jonathan M., et al.
Publicado: (2012)

Squamous intraepithelial lesions of the anal squamocolumnar junction: Histopathological classification and HPV genotyping
por: Clavero, Omar, et al.
Publicado: (2016)

Distribution of HPV Genotypes in Patients with a Diagnosis of Anal Cancer in an Italian Region
por: Muresu, Narcisa, et al.
Publicado: (2020)

Mapping HPV 16 Sub-Lineages in Anal Cancer and Implications for Disease Outcomes
por: Guerendiain, Daniel, et al.
Publicado: (2022)

Natural History of Anal HPV Infection in Women Treated for Cervical Intraepithelial Neoplasia
por: del Pino, Marta, et al.
Publicado: (2023)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

The Clinical Utility of Circulating HPV DNA Biomarker in Oropharyngeal, Cervical, Anal, and Skin HPV-Related Cancers: A Review
por: Andrioaie, Ioana Maria, et al.
Publicado: (2023)

Multi-institutional report on toxicities of concurrent nivolumab and radiation therapy
por: Amin, Neha P., et al.
Publicado: (2018)

The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT
por: Rimini, Margherita, et al.
Publicado: (2022)

Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
por: Chen, Yu-Pei, et al.
Publicado: (2015)

Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience
por: Chhatui, Bappaditya, et al.
Publicado: (2015)

Chemo-radiation with or without mandatory split in anal carcinoma: experiences of two institutions and review of the literature
por: Oehler, Christoph, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3751n3aedcbat3s8h4mrv3ba9r